As of Jul 02
| -0.003 / -0.54%|
The 4 analysts offering 12-month price forecasts for Cytori Therapeutics Inc have a median target of 5.00, with a high estimate of 7.00 and a low estimate of 1.25. The median estimate represents a +813.07% increase from the last price of 0.55.
The current consensus among 4 polled investment analysts is to Buy stock in Cytori Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.